Literature DB >> 2327360

Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty.

L H Young1, C C Jaffe, J H Revkin, P H McNulty, M Cleman.   

Abstract

Myocardial lactate metabolism and left ventricular function were studied in 12 patients during angioplasty of the left anterior descending artery performed with distal coronary perfusion (oxygenated and nonoxygenated Fluosol) and by conventional technique without distal perfusion. Before balloon inflation there was net lactate extraction by the heart (31 +/- 6%). During balloon inflations performed with distal perfusion there was net lactate release into the great cardiac vein while the balloon was inflated; the great cardiac vein lactate concentration was approximately 25% lower during perfusion with oxygenated versus nonoxygenated Fluosol (p less than 0.02) indicating less myocardial lactate release. After balloon deflation washout of lactate into the great cardiac vein (net myocardial release) was observed in all 3 protocols. Left ventricular ejection fraction measured by echocardiography decreased markedly during nonperfused (53 +/- 3 to 36 +/- 3%, p less than 0.001) and nonoxygenated Fluosol (52 +/- 2 to 30 +/- 3%, p less than 0.001) inflations. This dysfunction was largely prevented by oxygenated Fluosol where only a minimal decrease in ejection fraction (51 +/- 2 vs 48 +/- 2%, p less than 0.02) occurred. Analysis of regional contractile function yielded similar results. Although oxygenated perfluorocarbons decrease cardiac lactate release during angioplasty, this study provides evidence for the onset of lactate production even when ventricular function is preserved.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327360     DOI: 10.1016/0002-9149(90)91001-m

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy.

Authors:  Zaigang Zhou; Baoli Zhang; Wenjing Zai; Lin Kang; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-29       Impact factor: 11.205

Review 2.  Fighting Hypoxia to Improve PDT.

Authors:  Ludivine Larue; Bauyrzhan Myrzakhmetov; Amina Ben-Mihoub; Albert Moussaron; Noémie Thomas; Philippe Arnoux; Francis Baros; Régis Vanderesse; Samir Acherar; Céline Frochot
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-30

3.  Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine.

Authors:  Xing Jiang; Baoli Zhang; Zaigang Zhou; Lingtong Meng; Zhiling Sun; Yun Xu; Qiuping Xu; Ahu Yuan; Lixia Yu; Hanqing Qian; Jinhui Wu; Yiqiao Hu; Baorui Liu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy.

Authors:  Wenguang Wang; Yuhao Cheng; Peng Yu; Haoran Wang; Yue Zhang; Haiheng Xu; Qingsong Ye; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Nat Commun       Date:  2019-04-05       Impact factor: 14.919

Review 5.  Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice.

Authors:  Dirk Mayer; Katja Bettina Ferenz
Journal:  Eur J Appl Physiol       Date:  2019-11-04       Impact factor: 3.078

6.  Perftoran ® Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin.

Authors:  Amira M Gamal-Eldeen; Amani A Alrehaili; Afaf Alharthi; Bassem M Raafat
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

7.  Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells.

Authors:  Amira M Gamal-Eldeen; Amani A Alrehaili; Afaf Alharthi; Bassem M Raafat
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.